Why would they Novartis leave, when the treatment works, they looking forward more exposure to regenerative therapies, and reduces the mortality rates and reduces inflammation across critical organs.
Ann: Mesoblast Operational Highlights and Upcoming Milestones, page-45
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.020(1.38%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $2.870M | 1.967M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1093 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 25923 | 10 |
View Market Depth
| Last trade - 15.02pm 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |